You have 9 free searches left this month | for more free features.

lobaplatin

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Triple Negative Breast Cancer Trial in Beijing (Eribulin Mesylate, Lobaplatin)

Recruiting
  • Triple Negative Breast Cancer
  • Eribulin Mesylate
  • Lobaplatin
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Sep 15, 2022

Hepatocellular Carcinoma Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)

Recruiting
  • Hepatocellular Carcinoma Resectable
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Mar 1, 2023

Liver, Cancer of, Primary Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)

Recruiting
  • Liver, Cancer of, Primary Resectable
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Jan 18, 2023

Colorectal Cancer, Chemo Effect, Surgery Trial (Mitomycin, Lobaplatin)

Not yet recruiting
  • Colorectal Cancer
  • +4 more
  • (no location specified)
Feb 18, 2022

Gastric Cancer, Chemo Effect, Surgery Trial in Wuhan (Paclitaxel, Lobaplatin)

Recruiting
  • Gastric Cancer
  • +4 more
  • Wuhan, Hubei, China
    Wuhan Union Hospital
Feb 18, 2022

Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Radiation Oncology, Sun Yat-Sen University Cancer
Mar 10, 2023

Esophageal Cancer Trial in ZhengZhou (Lobaplatin, Cisplatin)

Completed
  • Esophageal Cancer
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Aug 26, 2020

Small Cell Lung Carcinoma Trial in Guangzhou (Anlotinib Hydrochloride, Lobaplatin, Etoposide)

Unknown status
  • Small Cell Lung Carcinoma
  • Anlotinib Hydrochloride
  • +2 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Guangzhou Medical University
Nov 26, 2019

Acute Toxic Effects, Tumor Responses Trial in Zhuhai (Lobaplatin, linear accelerator)

Completed
  • Acute Toxic Effects
  • Tumor Responses
  • Lobaplatin
  • linear accelerator
  • Zhuhai, Guangdong, China
    the Fifth Hospital Affiliated to Sun Yat-Sen University
Apr 7, 2018

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Guiyang (Lobaplatin, Cisplatin)

Unknown status
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Guiyang, Guizhou, China
    Cancer Hospital of Guizhou Medical University
Apr 14, 2017

Breast Cancer Trial in Harbin (lobaplatin, cisplatin)

Unknown status
  • Breast Cancer
  • Harbin, Heilongjiang, China
    Cancer Hospital of Harbin Medical University
Jan 22, 2012